Core Laboratories (CLB) Change in Accured Expenses (2022 - 2026)

Core Laboratories has reported Change in Accured Expenses for 5 years, with the latest figure at $47000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 92.38% year-over-year to $47000.0; the trailing twelve-month figure through Mar 2026 stood at -$3.3 million (down 192.53% YoY), and the FY2025 full-year result was -$2.7 million, down 689.35% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $47000.0, up from -$4.5 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $6.6 million in Q2 2024, with the low at -$5.7 million in Q4 2022.
• Historically, Change in Accured Expenses has averaged -$852200.0 across 5 years, with a median of -$1.1 million in 2024.
• The largest YoY upside for Change in Accured Expenses was 323.82% in 2024 against a maximum downside of 485.0% in 2024.
• Core Laboratories' Change in Accured Expenses stood at -$5.7 million in 2022, then jumped by 162.05% to $3.5 million in 2023, then plunged by 130.04% to -$1.1 million in 2024, then slumped by 322.89% to -$4.5 million in 2025, then surged by 101.04% to $47000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $47000.0 (Q1 2026), -$4.5 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.